Literature DB >> 21654110

The presence of dsRNA virus in Trichomonas vaginalis isolates from symptomatic and asymptomatic Indian women and its correlation with in vitro metronidazole sensitivity.

N Malla1, P Kaul, R Sehgal, I Gupta.   

Abstract

PURPOSE: Trichomonas vaginalis, a protozoan parasite, is the causative agent of human trichomoniasis, the most common non-viral sexually transmitted disease. The infection encompasses from a complete asymptomatic presentation to severe sequelae; yet, the virulence markers have been poorly understood. It is suggested that the presence of Trichomonas vaginalis virus (TVV) in T. vaginalis may have an impact on its virulence, and its relatedness to in vitro metronidazole resistance has been reported. The aim of the study was to assess the presence of TVV in fresh and Long -Term Cultivated ( LTC) maintained T. vaginalis isolates from symptomatic (S) and asymptomatic (AS) Indian women and its relatedness, if any, with symptomatology and in vitro drug sensitivity.
MATERIALS AND METHODS: One thousand women (537 S and 463 AS) were screened for the presence of T. vaginalis by wet smear and culture examination of vaginal swab and urine sample. Fresh and LTC (6 months-2 years) maintained 15 isolates each from 15 S and 15 AS women were subjected to agarose gel electrophoresis following total cellular RNA extraction to evaluate the presence of double stranded (ds) RNA viral infection. The susceptibility of isolates to metronidazole was determined in vitro.
RESULTS: On agarose gel electrophoresis, three bands (5.5, 2.5 and 1.5 kb) were observed in all the 30 fresh isolates from 15 S and 15 AS women and only in 7 LTC isolates from 3 S and 4 AS women. All the fresh isolates harbouring TVV were found to be sensitive to metronidazole in vitro irrespective of the symptomatology of subjects, and out of seven LTC isolates harbouring TVV, six were sensitive to metronidazole and one showed borderline resistance.
CONCLUSIONS: The results suggest that the presence of TVV alone may not be a virulence marker and loss of TVV on LTC appears to be related to drug resistance. The T. vaginalis Indian isolates are sensitive to metronidazole.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21654110     DOI: 10.4103/0255-0857.81801

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


  8 in total

1.  Trichomonas vaginalis Virus Among Women With Trichomoniasis and Associations With Demographics, Clinical Outcomes, and Metronidazole Resistance.

Authors:  Keonte J Graves; Arindam P Ghosh; Norine Schmidt; Peter Augostini; W Evan Secor; Jane R Schwebke; David H Martin; Patricia J Kissinger; Christina A Muzny
Journal:  Clin Infect Dis       Date:  2019-11-27       Impact factor: 9.079

2.  Trichomonas vaginalis infection in symbiosis with Trichomonasvirus and Mycoplasma.

Authors:  Raina Fichorova; Jorge Fraga; Paola Rappelli; Pier Luigi Fiori
Journal:  Res Microbiol       Date:  2017-03-31       Impact factor: 3.992

3.  A systematic review of the literature on mechanisms of 5-nitroimidazole resistance in Trichomonas vaginalis.

Authors:  Keonte J Graves; Jan Novak; W Evan Secor; Patricia J Kissinger; Jane R Schwebke; Christina A Muzny
Journal:  Parasitology       Date:  2020-07-30       Impact factor: 3.234

Review 4.  An Overview of Mucosa-Associated Protozoa: Challenges in Chemotherapy and Future Perspectives.

Authors:  Helena Lucia Carneiro Santos; Karina M Rebello
Journal:  Front Cell Infect Microbiol       Date:  2022-04-25       Impact factor: 6.073

Review 5.  Trichomonas vaginalis: pathogenicity and potential role in human reproductive failure.

Authors:  Ewelina Mielczarek; Joanna Blaszkowska
Journal:  Infection       Date:  2015-11-06       Impact factor: 3.553

6.  Molecular typing of Trichomonas vaginalis isolates by actin gene sequence analysis and carriage of T. vaginalis viruses.

Authors:  Simon C Masha; Piet Cools; Tania Crucitti; Eduard J Sanders; Mario Vaneechoutte
Journal:  Parasit Vectors       Date:  2017-10-30       Impact factor: 3.876

7.  Mycoplasma hominis impacts gene expression in Trichomonas vaginalis.

Authors:  Ursula Fürnkranz; Birgit Henrich; Julia Walochnik
Journal:  Parasitol Res       Date:  2018-01-24       Impact factor: 2.289

Review 8.  Viruses of protozoan parasites and viral therapy: Is the time now right?

Authors:  Paul Barrow; Jean Claude Dujardin; Nicolas Fasel; Alex D Greenwood; Klaus Osterrieder; George Lomonossoff; Pier Luigi Fiori; Robert Atterbury; Matteo Rossi; Marco Lalle
Journal:  Virol J       Date:  2020-09-29       Impact factor: 4.099

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.